An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Voice Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Material Removal
Based on TikTok, the platform has removed problematic material and banned related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.
After minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Pricing
Within these groups, posts show dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose users to possibly serious medical dangers”.
